The Recent Advances in the Serological Detection of Acute Myocardial InfarctionTaufner GH and Destefani AC*
Department of Biotechnology, Federal University of Espirito Santo (UFES), Av. Marechal Campos, 1468-Maruipe, Vitória, ES, Brazil
- *Corresponding Author:
- Afranio Cogo Destefani
Pharmacist Biochemist, PhD Student in Biotechnology from the Federal University of Espírito Santo (UFES)
Av. Marechal Campos, 1468-Maruipe, Vitória, ES-Brazil, CEP 29043-900
E-mail: [email protected]
Received Date: December 20, 2016; Accepted Date: December 27, 2016; Published Date: December 30, 2016
Citation: Taufner GH, Destefani AC (2016) The Recent Advances in the Serological Detection of Acute Myocardial Infarction. Clin Med Biochemistry 2:122. doi: 10.4172/2471-2663.1000122
Copyright: © 2016 Taufner GH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Acute Myocardial Infarction (AMI) is one of the leading causes of morbidity and mortality worldwide. The greatest risk of fatality occurs within the first hours of initiation of AMI. Thus, the early diagnosis of cardiac ischemia is fundamental for the effective management of AMI patients. Inadequate diagnosis of patients with chest pain often leads to inadequate admission of patients without AMI and vice versa. In addition to the clinical history, physical examination, accurate electrocardiogram findings, and evaluation of cardiac biomarkers play an important role in the early diagnosis of acute ischemia. The present review discusses in detail the various cardiac biomarkers released during the event of an AMI.